Moderna Pauses Plans for Vaccine Facility in Kenya Amidst Declining Demand

In a strategic move reflecting shifting dynamics in global vaccine demand, Moderna, a leading biotechnology company, has announced a pause on its plans to establish a vaccine manufacturing facility in Kenya. The decision follows a post-pandemic decline in demand for COVID-19 vaccines, prompting Moderna to reassess its manufacturing strategy to optimize costs. Modern's decision aligns with its broader initiative to resize its manufacturing network while maintaining a focus on research and development. The company is projected to invest approximately $4.5 billion this year alone...